Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, providing promising progress across numerous professional medical and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, ad